Moody's lifts Wyeth view to positive

Moody's Investors Service said it has revised Wyeth's outlook to positive from developing. At the same time, Moody's said it affirmed the ratings of Wyeth, including the Baa1 long-term senior unsecured debt rating and the Prime-2 short-term debt rating.

The outlook revision to positive reflects Wyeth's progress in resolving diet drug exposures, good trends for core products and the settlement with Teva Pharmaceutical Industries Ltd. earlier this year related to Effexor and Effexor XR patents.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.